U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
Immunoglobulin (G1_L-kappa)_scFv-G1(h-CH2-CH3), anti-[rabies lyssavirus (rabies virus, RABV) glycoprotein G epitope III] and anti-[rabies lyssavirus (rabies virus, RABV) glycoprotein G epitope I] Homo sapiens monoclonal antibody, bispecific
Preferred Name English
Silevimig
INN  
Official Name English
Immunoglobulin, anti-(rabies virus spike glycoprotein G) (human clone S2E3 single-chain Fv fragment VH-(GGGGS)3-VL) fusion protein with immunoglobulin G1 [5-serine,134-cysteine,151-serine,153-alanine,192-valine] (human ?1-chain C region C-terminal fragme
Common Name English
silevimig [INN]
Common Name English
Code System Code Type Description
INN
12660
Created by admin on Wed Apr 02 18:03:36 GMT 2025 , Edited by admin on Wed Apr 02 18:03:36 GMT 2025
PRIMARY
FDA UNII
K3CR9VL7SE
Created by admin on Wed Apr 02 18:03:36 GMT 2025 , Edited by admin on Wed Apr 02 18:03:36 GMT 2025
PRIMARY
NCI_THESAURUS
C203188
Created by admin on Wed Apr 02 18:03:36 GMT 2025 , Edited by admin on Wed Apr 02 18:03:36 GMT 2025
PRIMARY
CAS
2618667-99-3
Created by admin on Wed Apr 02 18:03:36 GMT 2025 , Edited by admin on Wed Apr 02 18:03:36 GMT 2025
PRIMARY
ACTIVE MOIETY
Silevimig
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966